[Congressional Record Volume 168, Number 133 (Saturday, August 6, 2022)]
[Senate]
[Page S4348]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5466. Mr. CASSIDY submitted an amendment intended to be proposed 
to amendment SA 5194 proposed by Mr. Schumer to the bill H.R. 5376, to 
provide for reconciliation pursuant to title II of S. Con. Res. 14; 
which was ordered to lie on the table; as follows:

        At the appropriate place, insert the following:

     SEC. __. ALLOWING COMMITTEES OF JURISDICTION ACCESS TO 
                   INFORMATION SUBMITTED BY PHARMACY BENEFIT 
                   MANAGERS FOR LEGISLATIVE PURPOSES.

       (a) In General.--Section 1150A(c) of the Social Security 
     Act (42 U.S.C. 1320b-23(c)) is amended by adding at the end 
     the following new paragraph:
       ``(5) To the Committee on Ways and Means and the Committee 
     on Energy and Commerce of the House of Representatives and 
     the Committee on Finance of the Senate, for the purposes of 
     providing congressional oversight and legislative 
     recommendations with respect to the Medicare prescription 
     drug program under part D of title XVIII.''.
       (b) Funding.--
       (1) In general.--In addition to amounts otherwise 
     available, there is appropriated to the Centers for Medicare 
     & Medicaid Services, out of any money in the Treasury not 
     otherwise appropriated, $900,000 for fiscal year 2022, to 
     remain available until expended, to carry out the provisions 
     of, including the amendments made by, this section.
       (2) Offsetting reduction in funding for drug price 
     negotiation.--Section 11004 is amended by striking 
     ``$3,000,000,000'' and inserting ``$2,999,000,000''.
                                 ______